AstraZeneca - Alvesco Omnaris and Zetonna Business - Ownership and Business Overview

Life ScienceCompany

AstraZeneca - Alvesco Omnaris and Zetonna Business Ownership

Who owns AstraZeneca - Alvesco Omnaris and Zetonna Business?

AstraZeneca - Alvesco Omnaris and Zetonna Business is owned by Covis Pharma Sàrl. It was acquired on November 6, 2018.

AstraZeneca - Alvesco Omnaris and Zetonna Business Business Overview

Where is AstraZeneca - Alvesco Omnaris and Zetonna Business headquartered?

AstraZeneca - Alvesco Omnaris and Zetonna Business is headquartered in London, United Kingdom.

What sector is AstraZeneca - Alvesco Omnaris and Zetonna Business in?

AstraZeneca - Alvesco Omnaris and Zetonna Business is a life science company.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

AstraZeneca Plc - Alvesco, Omnaris and Zetonna Business

London, W2 6BD
United Kingdom,

AstraZeneca Plc - Alvesco, Omnaris and Zetonna Business used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal symptoms associated with rhinitis. The rights cover markets outside the US and the US royalties for the medicines.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for AstraZeneca - Alvesco Omnaris and Zetonna Business

Life Science Companies , United Kingdom Companies